-
July 25, 2011 Lupin Settles Ongoing Litigation with Medicis over Generic Versions of SOLODYN®
-
July 7, 2011 Lupin announces tentative FDA Approval for Pregabalin Capsules
-
July 6, 2011 Lupin Launches Additional Strengths of Generic Lotrel® Capsules
-
June 23, 2011 Lupin in Alliance with Natco to commercialize generic equivalent of Tykerb® Tablets
-
June 22, 2011 Lupin Announces Launch of Generic Levaquin® Tablets for the US Market
-
June 15, 2011 Lupin acquires Worldwide Rights for the Goanna® Brand
-
June 10, 2011 HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
-
June 1, 2011 Lupin Announces Licensing Arrangement with NeuClone Inks strategic deal with NeuClone for Cell line Technology
-
May 12, 2011 6 Years of Sustained Growth Lupin Net Profit up by 27% in FY 2010-11
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications